QualityStocksNewsBreaks – Teewinot Life Sciences Corporation Awarded Broad US Patent
Cannabinoid-based pharmaceuticals company Teewinot Life Sciences Corporation this morning announced that it has been granted U.S. Patent No. 9,861,609. Per the update, the newly-issued patent has broad claims to biosynthetic methods for the pharmaceutical manufacture of cannabinoids and cannabinoid analogs. “With the grant of the '609 patent, Teewinot has now secured six U.S. patents covering processes for the manufacture of naturally-occurring cannabinoids, cannabinoid prodrugs and analogs using both biocatalysis and synthetic biology,” Dr. Richard Peet, Teewinot’s executive vice president and co-inventor of the new patent, stated in the news release. “Teewinot has filed patent applications in key countries around the…